UBX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,405.21

UNITY Biotechnology Insider Trading History Chart

UNITY Biotechnology Share Price & Price History

^$0.18

▼ -0.1215 (-40.43%)

As of 07/8/2025 08:59 PM ET

UNITY Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2025	Alexander Hieu Nguyen	Insider	Sell	1,954	$1.16	$2,266.64	22,605
2/4/2025	Alexander Hieu Nguyen	Insider	Sell	164	$2.23	$365.72	24,559
2/4/2025	Anirvan Ghosh	CEO	Sell	642	$2.23	$1,431.66	75,251
2/4/2025	Lynne Marie Sullivan	CFO	Sell	153	$2.23	$341.19	55,772
8/2/2024	Alexander Hieu Nguyen	Insider	Sell	154	$1.53	$235.62	24,872
8/2/2024	Anirvan Ghosh	CEO	Sell	604	$1.53	$924.12	76,325
8/2/2024	Lynne Marie Sullivan	CFO	Sell	139	$1.53	$212.67	56,061
6/25/2024	Alexander Hieu Nguyen	Insider	Sell	78	$1.40	$109.20	25,026
6/25/2024	Anirvan Ghosh	CEO	Sell	1,214	$1.40	$1,699.60	76,929
6/25/2024	Lynne Marie Sullivan	CFO	Sell	324	$1.40	$453.60	32,685
1/30/2024	Anirvan Ghosh	CEO	Sell	1,183	$1.71	$2,022.93	79,426
10/30/2023	Anirvan Ghosh	CEO	Sell	1,024	$1.90	$1,945.60	81,198
9/14/2023	Anirvan Ghosh	CEO	Sell	1,246	$2.47	$3,077.62	82,222
6/26/2023	Anirvan Ghosh	CEO	Sell	1,177	$3.20	$3,766.40	85,069
6/14/2023	Anirvan Ghosh	CEO	Sell	1,212	$3.39	$4,108.68	86,246
5/1/2023	Anirvan Ghosh	CEO	Sell	1,020	$2.15	$2,193.00	88
3/31/2023	Anirvan Ghosh	CEO	Sell	1,959	$1.70	$3,330.30	89,066
3/31/2023	Jamie Dananberg	Insider	Sell	420	$1.70	$714.00	62,817
3/14/2023	Anirvan Ghosh	CEO	Sell	1,210	$4.00	$4,840.00	91,025
3/14/2023	Jamie Dananberg	Insider	Sell	1,005	$4.00	$4,020.00	63,237
1/30/2023	Anirvan Ghosh	CEO	Sell	1,140	$4.45	$5,073.00	94,808
12/14/2022	Anirvan Ghosh	CEO	Sell	1,274	$2.85	$3,630.90	95,948
12/14/2022	Jamie Dananberg	Insider	Sell	1,016	$2.85	$2,895.60	65,105

SEC Filings (Institutional Ownership Changes) for UNITY Biotechnology (NASDAQ:UBX)

29.49% of UNITY Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

UNITY Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2025	Alyeska Investment Group L.P.	292,091	$0.30M	0.0%	-66.0%	1.697%
5/5/2025	Financial Harvest LLC	205,270	$0.21M	0.1%	N/A	1.193%
4/11/2025	SeaCrest Wealth Management LLC	27,800	$29K	0.0%	N/A	0.165%
2/17/2025	Bridgeway Capital Management LLC	50,000	$49K	0.0%	+100.0%	0.297%
2/17/2025	Alyeska Investment Group L.P.	859,083	$0.84M	0.0%	-6.6%	5.098%
2/13/2025	Renaissance Technologies LLC	76,911	$75K	0.0%	-17.9%	0.456%
11/16/2024	Geode Capital Management LLC	163,242	$0.24M	0.0%	+9.5%	0.969%
10/23/2024	Ballentine Partners LLC	57,046	$84K	0.0%	N/A	0.340%
8/9/2024	Renaissance Technologies LLC	64,582	$87K	0.0%	-39.6%	0.385%
2/13/2024	Armistice Capital LLC	688,000	$1.33M	0.0%	N/A	4.100%
8/9/2023	Mayo Clinic	124,081	$0.32M	0.3%	-21.1%	0.864%
7/27/2023	Virtu Financial LLC	17,949	$46K	0.0%	N/A	0.125%
5/16/2023	Founders Fund V Management LLC	49,172	$80K	6.2%	-90.0%	0.342%
5/1/2023	Arete Wealth Advisors LLC	10,392	$142.30B	0.0%	N/A	0.072%
2/14/2023	683 Capital Management LLC	240,000	$0.66M	0.1%	-91.5%	1.691%
2/9/2023	Mayo Clinic	157,198	$0.43M	0.2%	N/A	1.108%
2/8/2023	Prime Capital Investment Advisors LLC	11,420	$31K	0.0%	N/A	0.080%
2/7/2023	Commonwealth Equity Services LLC	16,013	$43K	0.0%	-62.8%	0.113%
2/6/2023	Arete Wealth Advisors LLC	10,392	$140.58B	0.0%	N/A	0.073%
2/2/2023	Bailard Inc.	17,700	$48K	0.0%	-65.3%	0.125%
1/26/2023	Mayo Clinic	157,198	$0.43M	2.2%	N/A	1.108%
11/16/2022	Maven Securities LTD	100,000	$40K	0.0%	N/A	0.705%
11/15/2022	Parkman Healthcare Partners LLC	404,092	$0.16M	0.0%	N/A	2.847%
11/15/2022	Laurion Capital Management LP	700,000	$0.28M	0.0%	N/A	4.933%
11/15/2022	Empery Asset Management LP	4,411,645	$1.74M	10.4%	N/A	31.090%
11/14/2022	683 Capital Management LLC	2,822,449	$1.12M	0.1%	N/A	19.888%
11/14/2022	Altium Capital Management LP	4,270,000	$1.69M	0.6%	N/A	30.087%
11/14/2022	UBS Oconnor LLC	606,500	$0.24M	0.0%	N/A	4.274%
11/14/2022	Maven Securities LTD	100,000	$40K	0.0%	N/A	0.705%
11/10/2022	ARCH Venture Management LLC	10,048,181	$3.97M	0.5%	N/A	75.059%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	162,043	$64K	0.0%	N/A	1.210%
11/10/2022	ExodusPoint Capital Management LP	509,892	$0.20M	0.0%	N/A	3.808%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	33,917	$38K	0.0%	-64.0%	0.049%
5/11/2022	GSA Capital Partners LLP	724,202	$0.81M	0.1%	+4.0%	1.047%
2/14/2022	GSA Capital Partners LLP	696,115	$1.02M	0.1%	+48.9%	1.206%
2/10/2022	Acadian Asset Management LLC	278,796	$0.41M	0.0%	N/A	0.483%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	94,282	$0.14M	0.0%	N/A	0.163%
11/16/2021	Two Sigma Advisers LP	155,200	$0.47M	0.0%	+178.6%	0.282%
11/16/2021	Two Sigma Investments LP	264,216	$0.79M	0.0%	+64.9%	0.479%
11/15/2021	Marshall Wace LLP	124,117	$0.37M	0.0%	+210.7%	0.225%
11/15/2021	Franklin Resources Inc.	92,900	$0.28M	0.0%	N/A	0.169%
11/15/2021	GSA Capital Partners LLP	467,371	$1.40M	0.1%	+127.0%	0.848%
11/12/2021	Renaissance Technologies LLC	640,700	$1.92M	0.0%	+25.0%	1.163%
11/12/2021	Geode Capital Management LLC	318,673	$0.96M	0.0%	+4.1%	0.578%
11/9/2021	BlackRock Inc.	900,630	$2.70M	0.0%	+2.0%	1.635%
11/8/2021	Russell Investments Group Ltd.	34,710	$0.10M	0.0%	-66.8%	0.063%
11/4/2021	Deutsche Bank AG	168,158	$0.50M	0.0%	-34.8%	0.305%
10/27/2021	Moloney Securities Asset Management LLC	21,000	$63K	0.0%	N/A	0.038%
9/3/2021	Parametric Portfolio Associates LLC	31,399	$0.15M	0.0%	-30.6%	0.057%

Data available starting January 2016

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.18

$0.20

$0.32

50 Day Range

MA: $0.43

$0.18

$0.88

52 Week Range

Now: $0.18

$0.20

$3.10

Volume

3,732,988 shs

Average Volume

284,137 shs

Market Capitalization

$3.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of UNITY Biotechnology?: UNITY Biotechnology's top insider shareholders include:
Anirvan Ghosh (CEO)
Lynne Marie Sullivan (CFO)
Alexander Hieu Nguyen (Insider)
Learn More about top insider investors at UNITY Biotechnology.
Who are the major institutional investors of UNITY Biotechnology?: UNITY Biotechnology's top institutional investors include:
Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of UNITY Biotechnology stock.
Which major investors are selling UNITY Biotechnology stock?: In the previous quarter, UBX stock was sold by these institutional investors:
Citadel Advisors LLC
Within the previous year, company insiders that have sold UNITY Biotechnology company stock include:
Anirvan Ghosh (CEO)
Lynne Marie Sullivan (CFO)
Alexander Hieu Nguyen (Insider)
Learn More investors selling UNITY Biotechnology stock.